Data sourcesSEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Public company
DGXQUEST DIAGNOSTICS INC
CIK 0001022079
Disclosed transactions18
Buys / sells1 / 3
Max Insider Score39
Connections9with evidence
DGX · disclosed activity on price
| Score | Actor | Security | Side | Value | Executed | Disclosed | Lag | Source | Evidence |
|---|
| 39 |  Carol D. MillerRSelf | DGXQUEST DIAGNOSTICS INC Sale | SELL | $15K – $50K | Mar 10, 2025 | Aug 13, 2026 traded Mar 10, 2025 | +521d | HOUSE PTR | |
|
39
 Julie JohnsonDJoint |
DGXQUEST DIAGNOSTICS INC Purchase |
| Aug 5, 2026 traded Oct 30, 2025 |
| 35 | Julie JohnsonDJoint | DGXQUEST DIAGNOSTICS INC Sale | SELL | $1,001 – $15K | Oct 30, 2025 | Aug 5, 2026 traded Oct 30, 2025 | +279d | HOUSE PTR | |
| 9 | KKKuppusamy KarthikSVP, Clinical Solutions | DGXQUEST DIAGNOSTICS INC Grant or award | A | — 9,853 sh | Feb 18, 2026 | Feb 20, 2026 traded Feb 18, 2026 | +2d | SEC FORM 4 | |
| 5 | DEDelaney Mark ESVP & Chief Commercial Officer | DGXQUEST DIAGNOSTICS INC Grant or award | A | — 7,332 sh | Feb 18, 2026 | Feb 20, 2026 traded Feb 18, 2026 | +2d | SEC FORM 4 | |
| 12 | KKKuppusamy KarthikSVP, Clinical Solutions | DGXQUEST DIAGNOSTICS INC Tax withholding | F | $53K 252 sh | Feb 18, 2026 | Feb 20, 2026 traded Feb 18, 2026 | +2d | SEC FORM 4 | |
| 12 | KKKuppusamy KarthikSVP, Clinical Solutions | DGXQUEST DIAGNOSTICS INC Tax withholding | F | $54K 259 sh | Feb 18, 2026 | Feb 20, 2026 traded Feb 18, 2026 | +2d | SEC FORM 4 | |
| 17 | KKKuppusamy KarthikSVP, Clinical Solutions | DGXQUEST DIAGNOSTICS INC Grant or award | A | — 2,135 sh | Feb 18, 2026 | Feb 20, 2026 traded Feb 18, 2026 | +2d | SEC FORM 4 | |
| 19 | KKKuppusamy KarthikSVP, Clinical Solutions | DGXQUEST DIAGNOSTICS INC Small acquisition | L | $2,936 16 sh | Jan 28, 2026 | Feb 20, 2026 traded Jan 28, 2026 | +23d | SEC FORM 4 | |
| 13 | DEDelaney Mark ESVP & Chief Commercial Officer | DGXQUEST DIAGNOSTICS INC Grant or award | A | — 1,586 sh | Feb 18, 2026 | Feb 20, 2026 traded Feb 18, 2026 | +2d | SEC FORM 4 | |
| 5 | DEDelaney Mark ESVP & Chief Commercial Officer | DGXQUEST DIAGNOSTICS INC Tax withholding | F | $43K 205 sh | Feb 18, 2026 | Feb 20, 2026 traded Feb 18, 2026 | +2d | SEC FORM 4 | |
| 5 | DEDelaney Mark ESVP & Chief Commercial Officer | DGXQUEST DIAGNOSTICS INC Tax withholding | F | $48K 230 sh | Feb 18, 2026 | Feb 20, 2026 traded Feb 18, 2026 | +2d | SEC FORM 4 | |
| 15 | DEDelaney Mark ESVP & Chief Commercial Officer | DGXQUEST DIAGNOSTICS INC Small acquisition | L | $2,753 15 sh | Jan 28, 2026 | Feb 20, 2026 traded Jan 28, 2026 | +23d | SEC FORM 4 | |
| 0 | DEDelaney Mark ESVP & Chief Commercial Officer | DGXQUEST DIAGNOSTICS INC Option exercise · 10b5-1 plan | M | $14K 100 sh | Nov 18, 2025 | Nov 20, 2025 traded Nov 18, 2025 | +2d | SEC FORM 4 | |
| 8 | DEDelaney Mark ESVP & Chief Commercial Officer | DGXQUEST DIAGNOSTICS INC Option exercise · 10b5-1 plan | M | $1.13M 7,846 sh | Nov 18, 2025 | Nov 20, 2025 traded Nov 18, 2025 | +2d | SEC FORM 4 | |
| 26 | DEDelaney Mark ESVP & Chief Commercial Officer | DGXQUEST DIAGNOSTICS INC Open-market sale · 10b5-1 plan | SELL | $1.49M 7,946 sh | Nov 18, 2025 | Nov 20, 2025 traded Nov 18, 2025 | +2d | SEC FORM 4 | |
| 0 | DEDelaney Mark ESVP & Chief Commercial Officer | DGXQUEST DIAGNOSTICS INC Option exercise · 10b5-1 plan | M | $14K 100 sh | Nov 18, 2025 | Nov 20, 2025 traded Nov 18, 2025 | +2d | SEC FORM 4 | |
| 20 | DEDelaney Mark ESVP & Chief Commercial Officer | DGXQUEST DIAGNOSTICS INC Option exercise · 10b5-1 plan | M | $1.13M 7,846 sh | Nov 18, 2025 | Nov 20, 2025 traded Nov 18, 2025 | +2d | SEC FORM 4 | |
LDA Q1 2026 first quarter · Health issues, Medicare/Medicaid · Aug 26, 2026